InvestSMART

Actinogen Medical Limited (ASX: ACW) - Announcements

Current share price for ACW : $0.044 0.003 (5.43%)+

ASX company news and announcements for Actinogen Medical Limited (ACW) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Actinogen Medical Limited (ACW) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Actinogen Medical Limited (ACW), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Actinogen Medical Limited (ACW)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$169 Announcement of non-renounceable rights issue 1 Jul 2013 11:28AM $0.010 $0.044 risen by 335%
$169 New Discovery for Plant Growth in Wheat, Peas and Broad Bean 18 Jun 2013 8:29AM $0.019 $0.044 risen by 128.95%
$169 Response to ASX Appendix 4C query 10 May 2013 3:21PM $0.013 $0.044 risen by 234.62%
$169 Appendix 4C - quarterly 30 Apr 2013 10:44AM $0.011 $0.044 risen by 295.45%
$169 Independent trials being conducted on Plant Growth Hormones 27 Mar 2013 1:38PM $0.016 $0.044 risen by 171.88%
$169 Appendix 4D and Half Year Accounts 28 Feb 2013 1:22PM $0.016 $0.044 risen by 171.88%
$169 Appendix 4C - quarterly 31 Jan 2013 5:13PM $0.012 $0.044 risen by 262.50%
$169 Response to ASX Appendix 4C Query 19 Nov 2012 12:34PM $0.021 $0.044 risen by 107.14%
$169 Appendix 4C - quarterly 29 Oct 2012 1:45PM $0.025 $0.044 risen by 74%
$169 Preliminary Final Report 31 Aug 2012 11:16AM $0.026 $0.044 risen by 67.31%
$169 Response to Appendix 4C ASX Query 13 Aug 2012 4:51PM $0.035 $0.044 risen by 24.29%
$169 Appendix 4C - quarterly 27 Jul 2012 1:09PM $0.035 $0.044 risen by 24.29%
$169 New Discovery of Making Shikimic Acid 25 Jul 2012 11:46AM $0.035 $0.044 risen by 24.29%
$169 NEW PATENT APPLICATION FOR BIOFUMIGATION PROCESS 21 May 2012 9:27AM $0.024 $0.044 risen by 81.25%
$169 Rights issue closure and notice of remaining shortfall 16 May 2012 12:50PM $0.026 $0.044 risen by 67.31%
$169 Further results in bio-ethanol test program 1 May 2012 10:45AM $0.032 $0.044 risen by 35.94%
$169 Appendix 4C - quarterly 26 Apr 2012 11:04AM $0.037 $0.044 risen by 17.57%
$169 Supplementary prospectus and amended timetable 12 Apr 2012 11:50AM $0.023 $0.044 risen by 89.13%
$169 Rights issue prospectus (with amended timetable) 27 Mar 2012 6:10PM $0.029 $0.044 risen by 50%
$169 Rights Issue Prospectus 22 Mar 2012 5:48PM $0.021 $0.044 risen by 107.14%
$169 Bio-ethanol Commercialisation Strategy 20 Mar 2012 2:18PM $0.026 $0.044 risen by 67.31%
$169 Appendix 4D and Half Yearly Accounts 29 Feb 2012 12:03PM $0.028 $0.044 risen by 55.36%
$169 Response to ASX query 10 Feb 2012 8:08PM n/a $0.044 n/a
$169 BIOFUEL PROGRAM UPDATE 31 Jan 2012 9:05AM $0.050 $0.044 fallen by 13%
$169 Appendix 4C - quarterly 27 Jan 2012 12:16PM $0.050 $0.044 fallen by 13%

851 - 875 of 915 results

Page 35 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.